PEG vs SPRY · P/E 18, rev $10.29B vs rev $89.1M
Public Service Enterprise Group Inc (PEG) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
PEG currently screens at market cap $39.57B and trailing P/E 17.6. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the PEG and SPRY stock pages for the full models.
Not investment advice.